abstract |
The present description relates to methods of treatment and pharmaceutical compositions comprising a Nitric Oxide Synthase-inducer peptide, PnPP-19. Although usable for other purposes, the composition comprising PnPP-19 is useful for treating and/or preventing eye diseases related to intraocular hypertension and/or optic nerve degeneration, such as glaucoma. |